+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Global Biologics Market Research Report: Forecast (2021-2026)

  • ID: 5439559
  • Report
  • July 2021
  • Region: Global
  • 197 Pages
  • MarkNtel Advisors LLP


  • Abbvie Inc.
  • Amgen Inc.
  • AstraZeneca Plc
  • Bristol-Myers Squibb
  • F. Hoffman La Roche
  • Merck & Co.

Market Overview

Biologics are drugs derived from living organisms or comprised of components of a living organism. It is available in the form of genetically engineered proteins. These drugs help in the treatment of chronic diseases, including cancer, neurology, and cardiovascular disorders.

According to the publishers’ research report, “Global Biologics Market Analysis, 2021,” the market is likely to grow at a CAGR of around 9% during 2021-26. The growth of the Biologics market is associated with several factors, such as the surging expenditures in healthcare, a hike in the sedentary lifestyles of individuals, and the rising number of chronic disease patients. Other factors driving the demand for biologics in the market include monoclonal antibodies for disease treatment and innovation & advancement in the healthcare & biotechnology sectors. Moreover, regulatory approval from the governments in different countries is also contributing to the growth of the Biologics market.

COVID-19 Pandemic Positively Impacted the Market Growth

The impact of COVID-19 has been leading to numerous research initiatives in biologics to find a suitable cure. Due to the pandemic, the global investments in biologics increased due to continuous demand for producing small molecule drugs. Thus, with the increasing number of COVID-19 cases, the need for biologics increased significantly. All the postponed treatments and consultations resumed in the last few months of 2020, which has resulted in aiding the number of treatment procedures using biologics. Hence, the Global Biologics Market is very likely to witness a significant surge in its growth rate in the forthcoming timeframe.

Market Segmentation

Vaccine Segment Accounted for the Largest Market Share

Based on the Product/Drug Class, the market bifurcates into Recombinant therapeutic Products, Monoclonal Antibodies, Hormones, Cytokines, Enzymes, Blood & Blood Components, Cellular & Gene Therapy, Vaccines, and Oligonucleotides. The vaccines segment acquired a considerable market share in the Global Biologics Market in the previous few years. The segment growth owes to the increasing government & non-government initiatives for vaccine R&D activities and the prevention of various infectious diseases. Moreover, the development of bivalent & pentavalent vaccines that can prevent an individual from more than one disease worldwide is another factor likely to fuel the segment growth, cites the authors in their research report, “Global Biologics Market Analysis, 2021.”

In-House Segment Dominated the Market

Based on Manufacturing Type, the market classifies into Outsource and In-house segments. Here, In-house manufacturing bagged the largest share in the Global Biologics Market in the previous few years. It owes to numerous companies opting for in-house manufacturing than to purchase the entity or outsource it entwined with the massive investments made by CMO’s for mushrooming commercial biopharmaceutical manufacturing capacity. However, the outsourcing segment is likely to showcase a gradual increase in demand in the coming years.

Regional Landscape

North America Region Attained the Highest Market Share

Geographically, North America held the largest market share in the Global Biologics Market in the previous few years. It owes to the spurring approvals in the US comprising larger patent protection than that in the European region. North America also witnessed the most prominent corona fatalities than other regions across the globe. This grim societal scenario is pushing the pharmaceutical giants to invest in biologics in cohesion with the governments. Other factors fueling the market growth in the region are growing diabetes patients, a surging aging population, and the availability of several research centers.

Market Driver

Spurring Demand for Biologics in Treatment of Chronic Diseases

Biologics are used profoundly for providing effective treatment for many complex diseases, such as rheumatoid arthritis and psoriasis, which have limited treatment options. With the advent of technology and innovation in the healthcare sector, there has been a significant escalation in amenities & equipment for rheumatoid arthritis patients who do not respond to traditional disease-modifying anti-rheumatic drugs. The key biologics used for treating rheumatoid arthritis are Adalimumab (HumiraInfliximab (Remicade), Anakinra (Kineret), Abatacept (Orencia), and Rituximab (Rituxan).

Market Challenge

Limitations in Production of Access Capacity

A successful product launch of biologics drugs needs a very long time for performing research and development activities. It also requires massive capital investments. In addition to this, the production of biological drugs is a complex procedure, and stringent government regulations often delay the same. Hence, these factors restrain the growth of the Biologics market across the globe to a certain extent.

Competitive Landscape

According to the publishers, the major leading players in the Global Biologics Market are Abbive Inc., Amgen Inc., F. Hoffman La Roche, Samsung Electronics, Merck & Co., AstraZeneca Plc., Bristol-Myers Squibb, Novartis, Pfizer, and Sanofi.

Key Questions Answered in the Market Research Report:

1. What are the overall market statistics or estimates (Market Overview, Market Size- by Value, Forecast Numbers, Market Segmentation, and Market Shares) of the Global Biologics Market?
2. What are the region-wise industry size, growth drivers, and challenges?
3. What are the key innovations, opportunities, current & future trends, and regulations in the Global Biologics Market?
4. Who are the key competitors, their key strengths & weaknesses, and how they perform in the Global Biologics Market based on a competitive benchmarking matrix?
5. What are the key results derived from the market surveys conducted during the Global Biologics Market study?
Note: Product cover images may vary from those shown


  • Abbvie Inc.
  • Amgen Inc.
  • AstraZeneca Plc
  • Bristol-Myers Squibb
  • F. Hoffman La Roche
  • Merck & Co.
1. Introduction
1.1. Product Definition
1.2. Research Process
1.3. Glossary
1.4. Market Segmentation

2. Executive Summary

3. Expert Verbatim- Interview Excerpts of 10 industry experts

4. Impact of COVID-19 on Global Biologics Market

5. Global Biologics Market Outlook, 2016-2026F
5.1. Market Size & Analysis
5.2. Market Share & Analysis

6. North America Biologics Market Outlook, 2016-2026F
6.1. Market Size & Analysis
6.2. Market Share & Analysis
6.3. US Biologics Market Outlook, 2016-2026F
6.4. Canada Biologics Market Outlook, 2016-2026F
6.5. Mexico Biologics Market Outlook, 2016-2026F

7. South America Biologics Market Outlook, 2016-2026F
7.1. Market Size & Analysis
7.2. Market Share & Analysis
7.3. Brazil Biologics Market Outlook, 2016-2026F
7.4. Argentina Biologics Market Outlook, 2016-2026F

8. Europe Biologics Market Outlook, 2016-2026F
8.1. Market Size & Analysis
8.2. Market Share & Analysis
8.3. UK Biologics Market Outlook, 2016-2026F
8.4. Germany Biologics Market Outlook, 2016-2026F
8.5. France Biologics Market Outlook, 2016-2026F
8.6. Italy Biologics Market Outlook, 2016-2026F
8.7. Spain Biologics Market Outlook, 2016-2026F

9. Asia-Pacific Biologics Market Outlook, 2016-2026F
9.1. Market Size & Analysis

10. Market Share & Analysis
10.1. By Therapeutic application
10.2. By Distribution Channel
10.3. By Manufacturing
10.4. By Product/Drug Class
10.5. By Country

11. China Biologics Market Outlook, 2016-2026F
11.1. Market Size & Analysis
11.2. Market Share & Analysis

12. India Biologics Market Outlook, 2016-2026F
12.1. Market Size & Analysis
12.2. Market Share & Analysis

13. Japan Biologics Market Outlook, 2016-2026F
13.1. Market Size & Analysis
13.2. Market Share & Analysis

14. Australia Biologics Market Outlook, 2016-2026F
14.1. Market Size & Analysis
14.2. Market Share & Analysis

15. South Korea Biologics Market Outlook, 2016-2026F
15.1. Market Size & Analysis
15.2. Market Share & Analysis

16. Middle East and Africa Biologics Market Outlook, 2016-2026F
16.1. Market Size & Analysis
16.2. Market Share & Analysis

17. UAE Biologics Market Outlook, 2016-2026F
17.1. Market Size & Analysis
17.2. Market Share & Analysis

18. Saudi Arabia Biologics Market Outlook, 2016-2026F
18.1. Market Size & Analysis
18.2. Market Share & Analysis

19. Global Biologics Dynamics
19.1. Drivers
19.2. Challenges
19.3. Impact Analysis

20. Global Biologics Regulations, Product Standards

21. Global Biologics Intellectual Property Rights Analysis

22. Global Biologics Hotspots & Opportunities

23. Competition Outlook
23.1. Competitor Wise Growth Strategies
23.2. Company Profiles

24. Disclaimer
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbvie Inc.
  • Amgen Inc.
  • F. Hoffman La Roche
  • Samsung Electronics
  • Merck & Co.
  • AstraZeneca Plc
  • Bristol-Myers Squibb
  • Novartis
  • Pfizer
  • Sanofi
Note: Product cover images may vary from those shown